Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative Dexmedetomidine for Prevention of Postoperative Atrial Fibrillation in Thoracic Surgery
NCT05320705Phase 1Unknown
- Sponsor
- Kasr Al Ainy Hospital
- Start
- Apr 2022
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dexmedetomidine in Atrial fibrillation (AFib) (2 arms), sponsored by Kasr Al Ainy Hospital. Primary endpoint: Incidence of new onset early atrial fibrillation at 72 hours. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT05320705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05320705.